Information About the COVID-19 Vaccines
Getting vaccinated is the best way to protect yourself, your loved ones, and your community from COVID-19. We currently have three vaccines available in the United States. All three vaccines are extremely effective at preventing serious illness and death. The vaccines made by Pfizer-BioNTech and Moderna require two shots, given about three to four weeks apart. The vaccine made by Johnson & Johnson (Janssen) requires one shot.
The Food and Drug Administration has granted full approval to the Pfizer-BioNTech COVID-19 vaccine for people ages 16 and older. Children ages 5 to 15 may receive the Pfizer-BioNTech vaccine under emergency use authorization (EUA). Also under EUA, the Moderna vaccine is available to those 17 and older, and the Johnson & Johnson vaccine is available to those 18 and older.
First Dose Appointment
Schedule your first vaccine dose appointment here.
To schedule a first dose appointment at Mount Sinai South Nassau, please visit the Mount Sinai South Nassau website or call 516-377-5333 for more information.
You can also check the New York State, New York City, New Jersey, or Connecticut websites for other locations that offer appointments or walk-in vaccination. New York City is also offering in-home vaccinations for all residents 12 and over, as well as mobile vaccination vans.
Patients ages 16 to 18 need parental/guardian consent for vaccination. Patients ages 5 to 15 must be accompanied by a parent or guardian.
Vaccination records from Mount Sinai are available through New York State’s digital app, Excelsior Pass.
Booster/Third Dose Appointment
Vaccine booster shots are available for those 18 years and older. If you received your second dose of the Pfizer or Moderna vaccine at least six months ago, you can now receive your booster. If you received your Johnson & Johnson vaccine at least two months ago, you can now receive your booster.
Please note, however, that some vaccine brands may not be available at all vaccination sites.
The Centers for Disease Control and Prevention (CDC) recommends that the following groups of people should get a booster shot: everyone aged 50 and over; everyone 18 and over whose first vaccine dose was the Johnson & Johnson vaccine; and those 18 and over who reside in long-term care settings. The CDC says that everyone aged 18 to 49 may receive a booster dose, based on individual risk-benefit assessment.
In addition, people who are age 12 and older and who are moderately or severely immunocompromised are eligible for an additional (third) dose of an mRNA vaccine (Pfizer-BioNTech or Moderna) as part of their primary series. This means you do not have to wait six months for the third dose. This includes many people who are getting treatment for cancer, have had organ transplants, or receive treatments that weaken their immune systems. In addition, if you have received a bone marrow transplant or CAR-T therapy, you may need to repeat your vaccine series if you were vaccinated before receiving these treatments.
To schedule a booster shot or third dose of the Pfizer or Moderna vaccines, click here to make an appointment at Mount Sinai. You can also check the New York State, New York City, New Jersey, or Connecticut websites for other locations.
Everyone receiving a booster shot will need to bring their original vaccine card with them to their appointment.
COVID-19 Vaccine Myths
There are a lot of myths on the internet about COVID-19 vaccines. Mount Sinai is working with a company called NewsGuard to provide the most accurate information. If you’ve heard something that sounds questionable and want to know if it’s true or not, you can look it up in NewsGuard’s report on the top COVID-19 vaccine myths.
Frequently Asked Questions about the COVID-19 Vaccine
Below are some helpful answers to the most frequently asked questions we receive about the COVID-19 vaccines.
In addition, a panel of Mount Sinai experts in infectious disease and clinical care have addressed some of the most common concerns about COVID-19 and vaccination in video roundtable discussions. They can be viewed here:
- Do the COVID-19 Vaccines Affect My Fertility?
- I’ve Had COVID-19, Do I Need Vaccine?
- Were the COVID-19 Vaccines Made Too Quickly?
- Why Should We Worry About the Delta Variant?
- Should I Get Vaccinated If I’m Pregnant?
The COVID-19 vaccines are free for everyone. You do not need health insurance to get vaccinated. If you do have insurance, please bring your card with you to your appointment. Your insurance may be billed but you will not be charged a co-pay or any other fees.
Most vaccination sites are not allowing for patients to choose which vaccine they get at this time. All of the vaccines are extremely effective at preventing serious illness and death. We recommend that you accept whichever vaccine you are offered and not wait for another vaccine to become available.
Yes. It is safe and recommended to get vaccinated as soon as you have recovered and no longer require isolation (usually 10 days after your symptoms began). If you have been treated for COVID-19 infection with monoclonal antibodies or convalescent plasma in the past 90 days, you should plan to get vaccinated after the recommended 90-day waiting period.
Yes. The Centers for Disease Control and Prevention (CDC) strongly recommends COVID-19 vaccination for people who are pregnant, breastfeeding, trying to get pregnant, or might become pregnant in the future. Pregnant people are more likely to get severely ill with COVID-19. Getting vaccinated will protect both you and your baby.
Excelsior Pass is a digital app that provides proof of your vaccination in New York State.
As required by New York State, all vaccinations performed at Mount Sinai are automatically sent to Excelsior Pass. Visit the Excelsior Pass website to learn more. To load your Mount Sinai vaccination record into Excelsior Pass, you will need to know the date of your second vaccination and the type of vaccine you were given. If you don’t remember this information, it is available through MyChart, our electronic health record portal.
If you have not yet downloaded MyChart, our electronic health record portal, we recommend that you do so. Step-by-step instructions can be found here.
Once you have set up MyChart, you can find your vaccination record by clicking on “Menu,” then “Health Summary,” then “Immunizations.” You should see your COVID-19 vaccination information, including the date(s) you were vaccinated and the name of the vaccine manufacturer. Be sure to enter this information, along with your name, date of birth, and other requested information, into the Excelsior Pass website or app exactly as it is recorded in MyChart.
If Excelsior Pass is still unable to locate your record, here are ways to get help:
Call the Mount Sinai COVID-19 Vaccine Reaction and Documentation Line at 646-605-5749
Contact Excelsior Pass at 844-699-7277 or via the web.
Contact the New York City Citywide Immunization Registry at 347-396-2400
If I got vaccinated outside the United States with a vaccine that is not used here, do I need to get revaccinated?
If you got vaccinated outside the United States, you may have been given a vaccine that has not received emergency use authorization from the U.S. Food and Drug Administration (FDA). As of May 2021, only the Pfizer-BioNTech, Moderna, and Johnson & Johnson (Janssen) vaccines have been authorized by the FDA.
If you received a different vaccine, here is guidance from the CDC and the New York City Department of Health and Mental Hygiene for what you should do:
If you received all recommended doses of a COVID-19 vaccine that is authorized for emergency use by the World Health Organization (WHO), you do not need to be vaccinated again. As of June 2021, the WHO list of authorized vaccines includes the AstraZeneca, Covishield (India), and Sinovac and Sinopharm (China) vaccines.
If you did not receive the full recommended number of doses of a WHO-listed COVID-19 vaccine, you may want to be revaccinated with the full recommended doses of a COVID-19 vaccine authorized by the FDA (i.e., two doses of the Pfizer or Moderna vaccines or a single dose of the Johnson & Johnson vaccine). If you received a vaccine that is not listed for emergency use by WHO, you may want to be revaccinated with an FDA-authorized COVID-19 vaccine.
You should wait at least 28 days between your last dose of the non-U.S. vaccine and your first dose in the United States.
No. COVID-19 antibody tests are designed to measure immunity resulting from infection, not from vaccination. These tests look for antibodies that are different from those made by current vaccines, so you won’t get a true picture of your protection.
If you have antibodies from a previous infection, those test results may not mean you are immune. On May 19, 2021, the FDA issued a safety warning stating that results from COVID-19 antibody tests should not be used to measure the level of protection from COVID-19 at any time.
If you regularly take aspirin, acetaminophen (e.g., Tylenol), or ibuprofen (e.g., Motrin or Advil) for other medical conditions, continue to do so as directed by your doctor or as needed. Otherwise, do not take these medications before getting vaccinated. Taking over-the-counter medications like these before receiving a vaccine may decrease your immune response to the vaccine, making it less effective. After vaccination, you can take an over-the-counter medication as needed to address any side effects from the vaccine.
In the United States, vaccines must be approved by the FDA before they can be used. The FDA bases its decision on data from clinical trials. In a clinical trial, the vaccine is given to volunteers—sometimes tens of thousands of them—while others get a placebo, meaning an injection that doesn’t contain any vaccine. Scientists observe whether the people who got the vaccine get fewer cases of the disease than those who got the placebo. This means that the vaccine appears to work in those people. How well a vaccine works is called “efficacy”. The scientists also watch out for unexpected side effects that the vaccine might have caused. This is called the vaccine’s “safety.”
If the clinical trial data shows enough evidence of efficacy and safety, the FDA will approve the vaccine and license it for use in the United States.
Sometimes, the FDA allows a medical product that has not yet been fully approved to be used in an emergency to diagnose, treat, or prevent a serious illness. This is called emergency use authorization or EUA.
An EUA may be issued when the FDA determines that the product “may be effective” against the disease based on all the available scientific evidence.
More information on EUAs is available from the FDA website.
The FDA reviews all vaccines for safety before allowing them onto the market. In New York State, the Governor’s Clinical Advisory Task Force, which includes highly respected scientists like Adolfo García-Sastre, PhD, Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai, also offers an independent opinion about each vaccine’s safety and efficacy.
If problems are discovered with a vaccine after its release, the FDA can recommend a pause in its use, as it did with the Johnson & Johnson vaccine after reports of rare but significant blood clots in several people who had taken the vaccine. After reviewing the data, the FDA decided to continue allowing its use with a warning about the rare clotting events on the label.
The Advisory Committee for Immunization Practices (ACIP), a group of medical and public health experts that advises the CDC, also assesses the safety and efficacy of vaccines. They helped to develop the recommendations on COVID-19 vaccine use.
Additionally, in New York State, the Governor’s Clinical Advisory Task Force independently reviews the vaccines as they are made available.
No. It is NOT possible to get COVID-19 from any of the vaccines available.
Like all vaccines, the COVID-19 vaccines can cause short-term side effects. These side effects are normal signs that your body is building up its protection against COVID-19. Side effects usually go away within a day or two and can be treated with over-the-counter pain medications.
The following side effects are common for the Moderna, Pfizer, and Johnson & Johnson vaccines:
- Pain in the arm where you received your shot
- Muscle pain
- Joint pain
If you experience side effects that are worrying or do not seem to go away after a few days, please tell your health care provider.
Serious side effects are extremely rare. Nearly 8 billion doses of the COVID-19 vaccines have been given worldwide, including more than 450 million in the United States. The safety of the vaccines is closely monitored—in fact, the COVID-19 vaccines are the most closely monitored vaccines in history.
There have been reports of people developing inflammation of the heart muscle (myocarditis) or the lining of the heart (pericarditis) after vaccination. These reports remain rare in the setting of millions of doses of vaccines being given. The conditions typically occur within a week of receiving the second dose of the Pfizer or Moderna vaccines, and they are more common in young males. It is important to remember that the risk of developing myocarditis or pericarditis from COVID-19 infection is greater than the risk from vaccination. Also, the cases from vaccination have been milder than cases from COVID-19 infection.
The CDC and the American Academy of Pediatrics continue to recommend COVID-19 vaccination as the best form of protection for adolescents.
A rare and serious type of blood clot has been reported in an extremely small number of patients who received the Johnson & Johnson (Janssen) vaccine. Women ages 18-49, especially, should be aware of the rare but increased risk of this side effect. This rare blot clot has not been associated with the Moderna or Pfizer vaccines. The FDA advises that people who have received the Johnson & Johnson vaccine should contact their health care provider if they develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination.
For more information about COVID-19 side effects, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
The Pfizer and Moderna vaccines both require two doses, given about three to four weeks apart. It is very important that you get both doses at the recommended times. The Johnson & Johnson vaccine requires only one dose.
People who are age 12 and older and who are moderately or severely immunocompromised are eligible for an additional (third) dose of an mRNA vaccine (Pfizer-BioNTech or Moderna) as part of their primary series. This includes many people who are getting treatment for cancer, have had organ transplants, or receive treatments that weaken their immune systems. In addition, if you have received a bone marrow transplant or CAR-T therapy, you may need to repeat your vaccine series if you were vaccinated before receiving these treatments.
Vaccine booster shots are available for those 18 years and older who received their second dose of the Pfizer or Moderna mRNA vaccines at least six months earlier or a single dose of the Johnson & Johnson (Janssen) vaccine at least two months earlier.
Allergies that are not related to medications or vaccines, such as allergies to foods, animals, and pollen, are not an issue. Do not get the Pfizer, Moderna, or Johnson & Johnson COVID-19 vaccine if you have had a severe allergic reaction (i.e., anaphylaxis) to vaccines or the components of that vaccine. If you have a history of severe medication allergies, please discuss with your health care provider.
Yes. While vaccines work the same in people of different races or ethnicities, it is important to make sure vaccines are tested in diverse population groups before they are released. The phase 3 clinical trials conducted by Pfizer and Moderna included significant numbers of participants from the population groups most at risk for COVID-19.
In Pfizer’s U.S. trial, 13.1 percent of participants are Hispanic/Latinx, 10.1 percent are Black, 5.5 percent are Asian American, and 1 percent are Native American. About 45 percent of U.S. participants are 56 to 85 years of age.
For comparison, in the most recent estimates by the U.S. Census Bureau, across the United States population, 18.4 percent of people are Hispanic/Latinx, 12.8 percent are Black, 5.7 percent are Asian American, and 0.9 percent are Native American. The Census uses slightly different age groups than the drug companies, but says that 27.4% of Americans are between ages 55 and 84.
Of the patients in Moderna’s trial, 9.7 percent identified as Black or African American, 20 percent as Hispanic/Latinx, 4.7 percent as Asian, and 0.8 percent as Native American. Also, 25.3 percent were over the age of 65 (compared to 16.5 percent in the general population), and 22.3 percent had at least one high-risk chronic disease, such as diabetes, severe obesity, or cardiac disease.
In Johnson & Johnson’s worldwide trials, 59 percent of patients were white, 45 percent were Hispanic and/or Latinx, and 19 percent were Black or African American. In their trial in the United States, 74 percent were white, 15 percent Hispanic/Latinx, and 13 percent Black or African American. Forty-one percent of participants in the Johnson & Johnson study had health conditions associated with an increased risk for severe COVID-19.
Researchers regularly test new medicines in a diverse population.
All three available vaccines are extremely effective at preventing hospitalization and death from COVID-19.
Vaccines expose us to pieces of either a bacteria or a virus. Our body’s immune system responds by making antibodies that fight against those pieces. The goal is that if we are exposed to the real bacteria or virus in the future, our body will recognize it and use the antibodies to fight it off.
There are several types of vaccines.
Traditional vaccines include pieces of the virus in them. This causes your immune system to react by making antibodies against those pieces.
The Pfizer and Moderna vaccines are called messenger RNA (mRNA) vaccines. They do not contain pieces of the virus. Instead, they contain instructions for your cells, called mRNA. This mRNA tells your cells to make a piece of the COVID-19 virus, called the spike protein. Once your cells make the spike protein, your immune system will make antibodies that fight the COVID-19 virus and protect you from getting sick.
The Johnson & Johnson vaccine also instructs your cells to make the COVID-19 spike protein themselves. Rather than using mRNA technology, however, it delivers those instructions by using a harmless adenovirus, similar to a common cold virus.
There is a lot of information on the internet about vaccines, and it can be difficult to know which sites to trust. Mount Sinai is providing a tool called NewsGuard, which is a browser extension (this adds features and functions to a browser) you can download that will help determine which information about vaccines and other health topics is accurate.
Medical researchers have not found any evidence that the COVID-19 vaccine impacts the menstrual cycle or period. Changes in the menstrual cycle are common and have a variety of causes. These may include stress, weight gain, changes in physical activity, and underlying medical conditions. Susan S. Khalil, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, encourages patients who notice irregularities in their cycle to contact a gynecologist.
Yes. The Pfizer-BioNTech vaccine has been shown to be 100 percent effective at preventing symptomatic infection in children ages 12 to 15, and 91 percent effective in children ages 5 to 11. The FDA has granted emergency use authorization for the Pfizer vaccine in both age groups. Moderna is testing its vaccine in two different age groups: children under 12 (including babies as young as 6 months), and children ages 12 to 17. The FDA has not yet authorized the Moderna vaccine for use in those age groups.